Ocumetics Announces Appointment of Raymond Marks to Board of Directors

(TheNewswire)

Calgary, Alberta – TheNewswire - February 24, 2026 -Ocumetics Technology Corp. (“Ocumetics” or the “Company”)(TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generationophthalmic technology, is pleased to announcethat Raymond Marks has been appointed to its Board ofDirectors.

Raymond Marks was instrumental in the early fundraisingefforts of the Company and participated in meetings that resulted inOcumetics securing financing for its initial public listing by reversetakeover.

He has over 50 years of experience as an entrepreneur,owner, operator and manager across a variety of industries includingthe resources and industrial sectors. Throughout his career, Mr. Markshas worked with many such companies and has worked with growingcompanies to secure millions in financing for their strategicinitiatives.

Mr. Marks previously co-founded Tudor Gold Corp.(TSXV:TUD) and served as executive Vice President, and a director ofTudor from February 2016 until October 2018. Mr. Marks later assistedin the formation of Hanstone Capital Corporation which later becameHanstone Gold Corp. where he served as President and Chief ExecutiveOfficer from October 2018 until October 2025. Mr. Marks helped secureover $16 million in financing for the two companies.

“We welcome Mr. Marks to the board of Ocumetics andlook forward to benefiting from his capital markets experience andassistance with our next stage of fundraising,” says Dean Burns,President and CEO of Ocumetics.

About Ocumetics

Ocumetics Technology Corp. (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO)is a Canadian research and product development company that isdedicated to developing advanced vision correction solutions thatenhance the quality of life for patients.  Through innovativeresearch and development, Ocumetics aims to transform the field ofophthalmology with state-of-the-art intraocular lenses and othervision-enhancing technologies.

Ocumetics is in the first-in-human early feasibilitystudy phase of a game-changing technology for the ophthalmic industry. Ocumetics has developed an intraocular lens that fits within thenatural lens compartment of the eye, potentially to eliminate the needfor corrective lenses.  It is designed to allow the eye’s naturalmuscle activity to shift focus from distance to near, providing clearvision at all distances without the help of glasses or contact lenses. 

FOR FURTHER INFORMATION, PLEASECONTACT:

Dave Burwell

Director, Investor Relations        

dave.burwell@ocumetics.com

 (403) 410-7907       

Neither the TSXVenture Exchange nor its Regulation Services Provider (as that term isdefined in the policies of the TSX Venture Exchange) acceptsresponsibility for the adequacy or accuracy of this release.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKINGINFORMATION: This news release includes certain “forward-lookingstatements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to,statements with respect to the commencement, timing and scope of theresearch and development to be conducted by the Company. Forward-looking statements are necessarily based upon a number ofestimates and assumptions that, while considered reasonable, aresubject to known and unknown risks, uncertainties, and other factorswhich may cause the actual results and future events to differmaterially from those expressed or implied by such forward-lookingstatements. Such factors include but are not limited to: operationalmatters, historical trends, current conditions and expected futuredevelopments, access to financing as well as other considerations thatare believed to be appropriate in the circumstances.  There can be noassurance that such statements will prove to be accurate, as actualresults and future events could differ materially from thoseanticipated in such statements. Accordingly, readers should not placeundue reliance on forward-looking statements.  The Company disclaimsany intention or obligation to update or revise any forward-lookingstatements, whether as a result of new information, future events orotherwise, except as required by law.

Copyright (c) 2026 TheNewswire - All rights reserved.